Episode 122: The Monsanto Saga and Launch of “Toxic Exposure” With Nassim Nicholas Taleb

Headshot of Nassim Taleb as the Featured Guest on Podcast Episode: The Monsanto Saga and Launch of “Toxic Exposure” With Nassim Taleb

Episode 122: The Monsanto Saga and Launch of “Toxic Exposure” With Nassim Nicholas Taleb

Today is the day of the official launch of Chadi’s first book “Toxic Exposure: The True Story behind the Monsanto Trials and the Search for Justice.” Throughout the book, Chadi details his experience as an expert physician witness and the true story of the first three litigation trials against Monsanto and their herbicide “Roundup” which is linked to the development of Non-Hodgkin Lymphoma.

The special guest on this unique day is the amazing icon and legend Dr. Nassim Nicholas Taleb. Nassim is beyond introduction; a best selling author of several books that contain concepts being taught in many schools. Nassim understands risk like no other and he is famous for predicting the Wall Street crash of 2008. Nassim found himself in the crosshairs with Monsanto, a story that he shares on the podcast.

Dr. Taleb read “Toxic Exposure,” generously offered his opinion, and shared that he liked it and that he would recommend it to his colleagues and followers. They talk about many things, from GMOs to ghostwriting and some of the finer details of the way Monsanto cherry-picked research to fit its arguments as well as how Chadi handled himself throughout the trials.

Related Resources

Subscribe to Healthcare Unfiltered

Other Episodes You May Enjoy...

Episode 206: Fireside Chat With Joe Mikhael, the CMO of the IMF

Dr. Joe Mikhael, Chief Medical Officer of the International Myeloma Foundation (IMF) and Professor at TGen, takes us beyond his medical career to explore the personal experiences that have shaped his journey in oncology. Dr. Mikhael discusses the IMF’s targeted strategies for reducing health disparities among diverse ethnic and racial groups affected by myeloma, shedding

Read More

Episode 205: Multi-Cancer Early Detection (MCED): Now and Later

Tom Beer, Chief Medical Officer of the Multi-Cancer Early Detection (MCED) program at Exact Sciences, delves into the groundbreaking science behind MCED tests, which use advanced biomarkers for early detection of multiple cancer types. On this Healthcare Unfiltered episode, he explains who may be eligible for these tests, how to interpret results to avoid unnecessary

Read More